BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16902162)

  • 1. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
    Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
    Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth state-dependent binding of USF-1 to a proximal promoter E box element in the rat plasminogen activator inhibitor type 1 gene.
    White LA; Bruzdzinski C; Kutz SM; Gelehrter TD; Higgins PJ
    Exp Cell Res; 2000 Oct; 260(1):127-35. PubMed ID: 11010817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
    Kutz SM; Higgins CE; Samarakoon R; Higgins SP; Allen RR; Qi L; Higgins PJ
    Exp Cell Res; 2006 Apr; 312(7):1093-105. PubMed ID: 16457817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
    Dong J; Fujii S; Li H; Nakabayashi H; Sakai M; Nishi S; Goto D; Furumoto T; Imagawa S; Zaman TA; Kitabatake A
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1078-84. PubMed ID: 15718495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z; Jhun B; Jung SY; Oh CK
    J Allergy Clin Immunol; 2008 Apr; 121(4):1006-1012.e2. PubMed ID: 18234320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR; Qi L; Higgins PJ
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstream stimulating factor-1 mediates the E-box-dependent transcriptional repression of the plasminogen activator inhibitor-1 gene in human mast cells.
    Ma Z; Jhun B; Oh CK
    FEBS Lett; 2007 Sep; 581(23):4485-90. PubMed ID: 17765897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAPK pathway and HIF-1 are involved in the induction of the human PAI-1 gene expression by insulin in the human hepatoma cell line HepG2.
    Dimova EY; Kietzmann T
    Ann N Y Acad Sci; 2006 Dec; 1090():355-67. PubMed ID: 17384280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concerted regulatory functions of the transcription factors nuclear factor-1 and upstream stimulatory factor on a composite element in the promoter of the hepatocyte growth factor gene.
    Jiang JG; Gao B; Zarnegar R
    Oncogene; 2000 May; 19(23):2786-90. PubMed ID: 10851080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
    Tan R; Zhang X; Yang J; Li Y; Liu Y
    J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
    Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
    Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications.
    Miyagawa R; Asakura T; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
    Coron Artery Dis; 2010 May; 21(3):144-50. PubMed ID: 20299979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
    Gaggioli C; Deckert M; Robert G; Abbe P; Batoz M; Ehrengruber MU; Ortonne JP; Ballotti R; Tartare-Deckert S
    Oncogene; 2005 Feb; 24(8):1423-33. PubMed ID: 15608673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
    Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
    Oishi K; Miyazaki K; Uchida D; Ohkura N; Wakabayashi M; Doi R; Matsuda J; Ishida N
    J Mol Cell Cardiol; 2009 Apr; 46(4):545-52. PubMed ID: 19168071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
    Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
    Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
    Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.